Eyedexoline Eye Drop is primarily indicated in conditions like Acromegaly, Acute epiglottitis, Anaerobic infections, Bacterial infections, Blepharitis, Brain abscesses, Brucellosis, Cellulitis, Corneal ulcers, Intraocular infections, Iron deficiency anaemia, Keratoconjuctivitis sicca, Life threatning infections, Meningitis, Peritonitis, Plague, Psittacosis, Q Fever, Septicaemia, Spotted fever, Tularemia, Typhoid, and can also be given in adjunctive therapy as an alternative drug of choice in Enteritis, Gangrene, Haemophilia, Influenza, Whipple’s disease.
Eyedexoline Eye Drop is contraindicated in conditions like Hypersensitivity.
The severe or irreversible adverse effects of Eyedexoline Eye Drop, which give rise to further complications include Encephalopathy, Pseudomembranous colitis, Urticaria, Thrombocytopenia, Hepatitis, Aplastic anemia, Hemolytic anemia, Aplastic anemia, Hemolytic anemia, Ototoxicity, Peripheral neuropathy, Optic neuritis, Hemolytic reactions, Interstitial nephritis, Hemolytic anemia, Aplastic anemia, Hair growth depression, Physical growth depression.Eyedexoline Eye Drop produces potentially life-threatening effects which include Bone marrow suppression, Grey baby syndrome, Anaphylaxis. which are responsible for the discontinuation of Eyedexoline Eye Drop therapy. The signs and symptoms that are produced after the acute overdosage of Eyedexoline Eye Drop include Grey baby syndrome. The symptomatic adverse reactions produced by Eyedexoline Eye Drop are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Vomiting, Diarrhea, Maculopapular rash, Stomatitis, Confusion, Pruritus, Depression, Glossitis, Delirium, Vision disturbances, Confusion, Transient stinging, Typhoid, Salmonella infection.
Evaluate blood count after every 2 days during therapy of Eyedexoline Eye Drop . Avoid concurrent therapy with other drugs that may cause bone marrow depression. It should be used with caution in case of liver or kidney disease. Discontinue therapy if secondry infection occurs.